Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Revenue
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
Cost of Revenue
--
--
--
--
Gross Profit
--
--
--
--
Selling, General & Admin
2
2
0
0
Research & Development
--
--
--
--
Operating Expenses
2
2
0
0
Other Non Operating Income (Expenses)
--
--
--
--
Pretax Income
0
0
0
0
Income Tax Expense
0
0
0
--
Net Income
0
0
0
0
Net Income Growth
--
--
--
--
Shares Outstanding (Diluted)
0
0
0
0
Shares Change (YoY)
-97%
0%
0%
--
EPS (Diluted)
-1,008.07
-1,015.95
735.29
0
EPS Growth
-5,049%
-238%
--
--
Free Cash Flow
0
0
0
0
Free Cash Flow Per Share
--
--
--
--
Gross Margin
--
--
--
--
Operating Margin
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
EBITDA
--
--
--
--
EBITDA Margin
--
--
--
--
D&A For EBITDA
--
--
--
--
EBIT
-2
-2
0
0
EBIT Margin
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
--
Follow-Up Questions
What are NewGenIvf Group Ltd's key financial statements?
According to the latest financial statement (Form-10K), NewGenIvf Group Ltd has a total asset of $21, Net loss of $0
What are the key financial ratios for NIVF?
NewGenIvf Group Ltd's Current ratio is 4.2, has a Net margin is 0, sales per share of $0.
How is NewGenIvf Group Ltd's revenue broken down by segment or geography?
NewGenIvf Group Ltd largest revenue segment is In Vitro Fertilization Treatment, at a revenue of 4,021,696 in the most earnings release.For geography, Kyrgyzstan is the primary market for NewGenIvf Group Ltd, at a revenue of 3,123,593.
Is NewGenIvf Group Ltd profitable?
no, according to the latest financial statements, NewGenIvf Group Ltd has a net loss of $0
Does NewGenIvf Group Ltd have any liabilities?
yes, NewGenIvf Group Ltd has liability of 5
How many outstanding shares for NewGenIvf Group Ltd?
NewGenIvf Group Ltd has a total outstanding shares of 0
Key Stats
Prev.Close
$1.87
Open
$1.98
Day's Range
$1.86 - $1.98
52 week range
$1.52 - $4,440
Volume
82.9K
Avg.Volume
194.0K
Dividend yield
--
EPS (TTM)
223.74
Market Cap
$1.8M
What is NIVF?
NewGenIvf Group Ltd is a TH-based company operating in Health Care Providers & Services industry. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 76 full-time employees. The company went IPO on 2022-02-15. NewGenIvf Group Limited is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. The company specializes in in-vitro fertilization (IVF) treatment and surrogacy and ancillary caring services. Its fertility treatments, such as IVF, intracytoplasmic sperm injection, intrauterine insemination, egg freezing, embryo transfer, gender selection, semen analysis, hysteroscopy, fertility checkups, testicular sperm aspiration and percutaneous epididymal sperm aspiration. Its clinics are in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions. The company has acquired cytometry technology and assets including 18 fully constructed cell-sorting and dispensing systems, eight partially constructed units and six patents related to advanced microfluidic systems.